Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells

Melanoma Research

Volumn 18, Issue 5, 2008, Pages 322-329

  Chen, Junxia ^a   Peng, Huimin ^a   Ou Yang, Xi ^a   He, Xiaoyan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Ginsenoside Rg3; Melanoma; Metastasis; Tumor treatment

Indexed keywords

BETA ACTIN; CASPASE 3; GINSENOSIDE RG 3; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DENSITY; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG WEIGHT; MALE; MELANOMA B16; MELANOMA CELL; METASTASIS INHIBITION; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SURVIVAL TIME; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GINSENOSIDES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS;

EID: 53549093298     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32830b3536     Document Type: Article

References (25)

1. Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE. Transcriptional regulation of the melanoma prognostic marker molastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Res 2004; 64:509-516.
2. Zhu BK, Pruitt SC. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line. Melanoma Res 2005; 15:363-373.
3. Lin SY, Lai WW, Chou CC, Kuo HM, Li TM, Chung JG, et al. Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells. Melanoma Res 2006; 16:509-519.
4. El-Bayoumy K, Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 2004; 551:181.
5. Kitts DD, Popovich DG, Hu C. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells. Can J Physiol Pharmacol 2007; 85:1173-1183.
6. Fujita K, Hakuba N, Hata R, Morizane I, Yoshida T, Shudou M, et al. Ginsenoside Rb1 protects against damage to the spiral ganglion cells after cochlear ischemia. Neurosci Lett 2007; 415:113-117.
7. Wang CZ, Zhang B, Song WX, Wang A, Ni M, Luo X, et al. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J Agric Food Chem 2006; 54:9936-9942.
8. Kitagawa I, Yoshikawa M, Yoshihara M. Chemical studies of crude drugs. Constituents of Ginseng radix rubra. Yakugaku Zasshi 1983; 103:612.
9. Ivanova T, Han Y, Son HJ, Yun YS, Song JY. Antimutagenic effect of polysaccharide ginsan extracted from Panax ginseng. Food Chem Toxicol 2006;44:517-521.
10. Panwar M, Kumar M, Samarth R, Kumar A. Evaluation of chemopreventive action and antimutagenic effect of the standardized Panax ginseng extract, EFLA400, in Swiss albino mice. Phytother Res 2005; 19:65-71.
11. Wang CZ, Xie JT, Zhang B, Ni M, Fishbein A, Aung HH, et al. Chemopreventive effects of Panax notoginseng and its major constituents on SW48O human colorectal cancer cells. Int J Oncol 2007; 31: 1149-1156.
12. Zhang Q, Kang X, Zhao W. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun 2006; 342:824-828.
13. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, et al. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 2007; 73:669-674.
14. Chen ZJ, Cheng J, Huang YP, Han SL, Liu NX, Zhu GB, et al. Effect of adjuvant chemotherapy of ginsenoside Rg3 combined with mitomycin C and tegafur in advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2007; 10:64-66.
15. Yue PY, Wong DY, Wu PK, Leung PY, Mak NK, Yeung HW, et al. The angiosuppressive effects of 2O(R)- ginsenoside Rg3. Biochem Pharmacol 2006; 72:437-445.
16. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002; 25:323-344.
17. Shimizu K, Sawazaki Y, Tanaka T, Asai T, Oku N. Chronopharmacologic cancer treatment with an angiogenic vessel-targeted liposomal drug. Biol Pharm Bull 2008; 31:95-98.
18. Xu TM, Xin Y, Cui MH, Jiang X, Gu LP. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chin Med J 2007; 120:584-588.
19. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004; 27:429-435.
20. Aharoni D, Dantes A, Oren M, Amsterdam A, Oren M. AMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp Cell Res 1995; 218:271-282.
21. Kung AL, Zetterberg A, Sherwood SW, Aharoni D, Dantes A, Oren M, Amsterdam A. Cytotoxic effects of cell cycle phase specific agent: result of cell cycle perturbation. Cancer Res 1990; 50:7307-7317.
22. Xie SQ, Wu YL, Cheng PF, Wang MW, Liu GC, Ma YF, et al. A novel homospermidine conjugate inhibits growth and induces apoptosis in human hepatoma cells. Acta Pharmacol Sin 2007; 28:1827-1834.
23. Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, et al. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells. Oncol Rep 2008; 19:517-526.
24. Fernández-Luna JL. Apoptosis regulators as targets for cancer therapy. Clin Transl Oncol 2007; 9:555-562.
25. Cronin D, Daly C, O'Doherty T, Fernández-Luna JL. Construction and transfection of a ribozyme targeting human caspase-3. Anticancer Res 2004; 24:425-431.